RenovoRx, Inc.RNXTNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
6.32%
↓ 56% below average
Average (5y)
14.43%
Historical baseline
Range
High:41.53%
Low:-20.39%
Volatility
429.0%
High variability
| Period | Value |
|---|---|
| 2024 | 6.32% |
| 2023 | 31.76% |
| 2022 | 41.53% |
| 2021 | 27.37% |
| 2020 | -20.39% |
| 2019 | 0.00% |